160 related articles for article (PubMed ID: 37590164)
41. Molecular dissection of the intrinsic factor-vitamin B12 receptor, cubilin, discloses regions important for membrane association and ligand binding.
Kristiansen M; Kozyraki R; Jacobsen C; Nexø E; Verroust PJ; Moestrup SK
J Biol Chem; 1999 Jul; 274(29):20540-4. PubMed ID: 10400683
[TBL] [Abstract][Full Text] [Related]
42. Plasma Membrane Repair Is Regulated Extracellularly by Proteases Released from Lysosomes.
Castro-Gomes T; Corrotte M; Tam C; Andrews NW
PLoS One; 2016; 11(3):e0152583. PubMed ID: 27028538
[TBL] [Abstract][Full Text] [Related]
43. Development of Triantennary N-Acetylgalactosamine Conjugates as Degraders for Extracellular Proteins.
Zhou Y; Teng P; Montgomery NT; Li X; Tang W
ACS Cent Sci; 2021 Mar; 7(3):499-506. PubMed ID: 33791431
[TBL] [Abstract][Full Text] [Related]
44. Intracellular trafficking of lysosomal membrane proteins.
Hunziker W; Geuze HJ
Bioessays; 1996 May; 18(5):379-89. PubMed ID: 8639161
[TBL] [Abstract][Full Text] [Related]
45. Intramembrane proteolysis within lysosomes.
Schröder B; Saftig P
Ageing Res Rev; 2016 Dec; 32():51-64. PubMed ID: 27143694
[TBL] [Abstract][Full Text] [Related]
46. β2-microglobulin amyloid fibrils are nanoparticles that disrupt lysosomal membrane protein trafficking and inhibit protein degradation by lysosomes.
Jakhria T; Hellewell AL; Porter MY; Jackson MP; Tipping KW; Xue WF; Radford SE; Hewitt EW
J Biol Chem; 2014 Dec; 289(52):35781-94. PubMed ID: 25378395
[TBL] [Abstract][Full Text] [Related]
47. Proteasomal and lysosomal degradation for specific and durable suppression of immunotherapeutic targets.
Wang Y; Deng S; Xu J
Cancer Biol Med; 2020 Aug; 17(3):583-598. PubMed ID: 32944392
[TBL] [Abstract][Full Text] [Related]
48. ROTACs leverage signaling-incompetent R-spondin for targeted protein degradation.
Sun R; Meng Z; Lee H; Offringa R; Niehrs C
Cell Chem Biol; 2023 Jul; 30(7):739-752.e8. PubMed ID: 37321224
[TBL] [Abstract][Full Text] [Related]
49. Directed evolution of genetically encoded LYTACs for cell-mediated delivery.
Yang JL; Yamada-Hunter SA; Labanieh L; Sotillo E; Cheah JS; Roberts DS; Mackall CL; Bertozzi CR; Ting AY
Proc Natl Acad Sci U S A; 2024 Mar; 121(13):e2320053121. PubMed ID: 38513100
[TBL] [Abstract][Full Text] [Related]
50. The Potential of Proteolytic Chimeras as Pharmacological Tools and Therapeutic Agents.
Coll-Martínez B; Delgado A; Crosas B
Molecules; 2020 Dec; 25(24):. PubMed ID: 33339292
[TBL] [Abstract][Full Text] [Related]
51. Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders.
Gadiyar V; Patel G; Chen J; Vigil D; Ji N; Campbell V; Sharma K; Shi Y; Weiss MM; Birge RB; Davra V
Front Immunol; 2023; 14():1135373. PubMed ID: 37545504
[TBL] [Abstract][Full Text] [Related]
52. The Lysosome Pathway Degrades CD81 on the Cell Surface by Poly-ubiquitination and Clathrin-Mediated Endocytosis.
Hosokawa K; Ishimaru H; Watanabe T; Fujimuro M
Biol Pharm Bull; 2020 Mar; 43(3):540-545. PubMed ID: 31902824
[TBL] [Abstract][Full Text] [Related]
53. Neuraminidase of Influenza A Virus Binds Lysosome-Associated Membrane Proteins Directly and Induces Lysosome Rupture.
Ju X; Yan Y; Liu Q; Li N; Sheng M; Zhang L; Li X; Liang Z; Huang F; Liu K; Zhao Y; Zhang Y; Zou Z; Du J; Zhong Y; Zhou H; Yang P; Lu H; Tian M; Li D; Zhang J; Jin N; Jiang C
J Virol; 2015 Oct; 89(20):10347-58. PubMed ID: 26246576
[TBL] [Abstract][Full Text] [Related]
54. Modular cytokine receptor-targeting chimeras for targeted degradation of cell surface and extracellular proteins.
Pance K; Gramespacher JA; Byrnes JR; Salangsang F; Serrano JC; Cotton AD; Steri V; Wells JA
Nat Biotechnol; 2023 Feb; 41(2):273-281. PubMed ID: 36138170
[TBL] [Abstract][Full Text] [Related]
55. LYST affects lysosome size and quantity, but not trafficking or degradation through autophagy or endocytosis.
Holland P; Torgersen ML; Sandvig K; Simonsen A
Traffic; 2014 Dec; 15(12):1390-405. PubMed ID: 25216107
[TBL] [Abstract][Full Text] [Related]
56. Multifaceted targeted protein degradation systems for different cellular compartments.
Zorca CE; Fallahi A; Luo S; Eldeeb MA
Bioessays; 2022 Jun; 44(6):e2200008. PubMed ID: 35417040
[TBL] [Abstract][Full Text] [Related]
57. A novel mechanism for the autonomous termination of pre-B cell receptor expression via induction of lysosome-associated protein transmembrane 5.
Kawano Y; Ouchida R; Wang JY; Yoshikawa S; Yamamoto M; Kitamura D; Karasuyama H
Mol Cell Biol; 2012 Nov; 32(21):4462-71. PubMed ID: 22949502
[TBL] [Abstract][Full Text] [Related]
58. Lys-63-linked Ubiquitination of γ-Aminobutyric Acid (GABA), Type B1, at Multiple Sites by the E3 Ligase Mind Bomb-2 Targets GABAB Receptors to Lysosomal Degradation.
Zemoura K; Trümpler C; Benke D
J Biol Chem; 2016 Oct; 291(41):21682-21693. PubMed ID: 27573246
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
